COVID, Biologics, and Psoriasis Therapy.

Elston, Dirk M

Elston, Dirk M.

Elston DM; Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, South Carolina. Electronic address: elstond@musc.edu.

J Am Acad Dermatol ; 83(6): 1577-1578, 2020 12.

Article in English | MEDLINE | ID: covidwho-872161

Subject(s)

Biological Products/administration & dosage; COVID-19/immunology; Cytokine Release Syndrome/prevention & control; Immunologic Factors/administration & dosage; Psoriasis/drug therapy; Biological Products/adverse effects; COVID-19/complications; COVID-19/mortality; COVID-19/transmission; Clinical Trials as Topic; Cytokine Release Syndrome/immunology; Cytokine Release Syndrome/mortality; Decision Making, Shared; Dermatology/standards; Glucocorticoids/administration & dosage; Glucocorticoids/adverse effects; Glucocorticoids/standards; Humans; Immunologic Factors/adverse effects; Immunologic Factors/standards; Practice Guidelines as Topic; Psoriasis/immunology; SARS-CoV-2/immunology; Symptom Flare Up

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / Biological Products / Cytokine Release Syndrome / COVID-19 / Immunologic Factors Type of study: Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: J Am Acad Dermatol Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google